Clinical Trial Results - Progress in Cancer Care
These summaries highlight recently released results from cancer clinical trials. The findings are significant enough that they are likely to influence your medical care.
The summaries are listed in reverse chronological order. You may also use the navigation tools on the left to search the summaries by keyword or type of cancer.
- Weight Lifting Does Not Exacerbate and May Improve Lymphedema Symptoms After Breast Cancer
(Posted: 09/16/2009) - Slowly progressive weight lifting did not aggravate limb swelling among breast cancer survivors with lymphedema, according to a randomized clinical trial in the August 13, 2009, issue of The New England Journal of Medicine.
- Radiofrequency Ablation Effective Against Barrett Esophagus
(Posted: 07/23/2009) - In a randomized phase II trial, radiofrequency ablation led to high rates of eradication of the cell abnormalities associated with Barrett esophagus, according to the May 28, 2009, New England Journal of Medicine.
- For Children with Leukemia, Radiation May Be Unnecessary
(Posted: 07/23/2009) - Children with the most common form of leukemia can safely forego radiation therapy to prevent relapse if they are treated with chemotherapy regimens tailored to their individual needs, according to the June 25, 2009, New England Journal of Medicine.
- Donated Stem Cell Transplants Better than Self-transplants for Most Patients with AML
(Posted: 07/23/2009) - Evidence from a meta-analysis of prospective clinical trials supports the use of donated (or allograft) stem cell transplants to treat most individuals with acute myeloid leukemia, according to the June 10, 2009, Journal of the American Medical Association.
- Sorafenib Delays Progression of Metastatic Kidney Cancer
(Posted: 02/07/2007, Updated: 06/08/2009) - The targeted drug sorafenib (Nevaxar®), which delays disease progression in patients with metastatic kidney cancer, may also improve survival of such patients, according to the May 18, 2009, Journal of Clinical Oncology.